HFE Mutation and Dietary Iron Content Interact to Increase Ischemia/Reperfusion Injury of the Heart in Mice

Abstract —Hereditary hemochromatosis is an inherited pathological condition characterized by iron overload in several vital organs including heart. To increase our understanding of the underlying pathogenic mechanisms of hereditary hemochromatosis, we used a HFE gene knockout mouse model that replicates hereditary hemochromatosis. A group of mice with no copies of HFE gene and corresponding wild‐type mice were maintained either on low‐iron (30 ppm) or high‐iron (300 ppm) diet since birth. The results of our study revealed that HFE gene knockout mouse hearts were susceptible to ischemia‐reperfusion injury as evidenced by increased postischemic ventricular dysfunction, increased myocardial infarct size and cardiomyocyte apoptosis compared with wild‐type control hearts. The degree of injury increased in the hearts of the mice fed high‐iron diet. The hearts of the HFE knockout mice showed increased iron deposition, increased content of reactive oxygen species (ROS) as evidenced by the increased formation of malondialdehyde, and reduced antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase. The results suggest that increased amount of ROS and reduced antioxidant reserve secondary to iron overloading may be instrumental for the susceptibility of the HFE gene knockout mice to cardiac injury. (Circ Res. 2003;92:1240–1246.)

[1]  R. Mason,et al.  Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: an ESR spin-trapping investigation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Reunanen,et al.  Body iron stores and risk of cancer , 1994, International journal of cancer.

[3]  B. Halliwell,et al.  Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. , 1985, Clinical science.

[4]  W. Sly,et al.  HFE gene knockout produces mouse model of hereditary hemochromatosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Maulik,et al.  Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase , 2004, Molecular and Cellular Biochemistry.

[6]  L. Jorde,et al.  Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. , 1996, The New England journal of medicine.

[7]  R. Bolli,et al.  Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning". , 1990, The American journal of physiology.

[8]  B. Halliwell,et al.  Oxygen toxicity, oxygen radicals, transition metals and disease. , 1984, The Biochemical journal.

[9]  F. Collins,et al.  Hereditary hemochromatosis: gene discovery and its implications for population-based screening. , 1998, JAMA.

[10]  N. Maulik,et al.  Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. , 1995, Journal of molecular and cellular cardiology.

[11]  W. Roberts,et al.  Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy. , 1980, The American journal of medicine.

[12]  W. Sly,et al.  Mechanisms of iron accumulation in hereditary hemochromatosis. , 2002, Annual review of physiology.

[13]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[14]  R. Hajjar,et al.  Apoptosis in the failing heart. , 1998, Cardiology clinics.

[15]  I. Young,et al.  Antioxidant status and lipid peroxidation in hereditary haemochromatosis. , 1994, Free radical biology & medicine.

[16]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[17]  I. Moraru,et al.  Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress. , 1995, Journal of molecular and cellular cardiology.

[18]  L. Tesoriere,et al.  Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. , 1996, Blood.

[19]  L. E. Anderson,et al.  Hemochromatosis Heterozygotes May Constitute a Radiation-Sensitive Subpopulation , 2000, Radiation Research.

[20]  N. Maulik,et al.  Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. , 1998, Free radical biology & medicine.

[21]  G. Anderson,et al.  Of metals, mice, and men: what animal models can teach us about body iron loading. , 2000, The Journal of clinical investigation.

[22]  W. Burke,et al.  HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. , 2001, American journal of epidemiology.

[23]  D. Lehotay,et al.  Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload. , 1999, Cardiovascular research.

[24]  D. Das,et al.  Transgene overexpression of αB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion , 2001 .

[25]  M. Weisfeldt,et al.  Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. , 1987, Circulation.

[26]  N. Maulik,et al.  Antioxidant effectiveness in ischemia-reperfusion tissue injury. , 1994, Methods in enzymology.

[27]  L. Powell BROADSHEET NUMBER 54: HEREDITARY HEMOCHROMATOSIS , 2000, Pathology.